AMA submission to the Therapeutic Goods Administration – Proposed amendments to the Poisons Standard – November 2021

In this submission, the AMA supports new warning statements for astodrimer sodium to reflect the new indication for the prevention of recurrent bacterial vaginosis. The AMA opposes the proposal to exempt throat sprays from scheduling. The AMA supports the intention behind the proposal for a schedule 3 entry for choline salicylate.